Expanding Product Line SOMAÍ Pharmaceuticals has recently launched its EU-GMP full-spectrum Essentials line extracts, showcasing their focus on high-quality, pharmaceutical-grade cannabis products. This provides opportunities to target medical dispensaries, hospitals, and clinics seeking reliable, full-spectrum extracts.

Strategic Partnerships The company has formed multiple distribution and partnership agreements with entities like Sherbinskis, Releaf Dispensary, and Canymed GmbH, indicating an active expansion into European markets and opportunities to collaborate with local distributors and healthcare providers.

International Acquisitions Recent acquisition of RPK Biopharma and ongoing global brand partnerships position SOMAÍ as a rapidly growing player with a diverse product portfolio, opening sales prospects in international markets and therapeutic applications.

Manufacturing Expertise With a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, SOMAÍ offers scalable, high-quality production capabilities ideal for partners looking to secure consistent supply of pharmaceutical-grade cannabis extracts.

Global Market Focus SOMAÍ’s presence in major European markets and global sales teams through its multi-country operator model create opportunities to approach regional healthcare systems, pharmacies, and medical cannabis clinics seeking compliant, innovative therapeutics.